Home / Pharmaceutical company intelligence
Scotmann Pharmaceuticals logo
Pharmaceutical company intelligence

Scotmann Pharmaceuticals

Pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-based pharmaceutical manufacturer with general medicines and nutraceutical products, nationwide distribution and accredited quality-control capabilities.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation25 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date20 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
5-D, I-10/3, Industrial Area, Islamabad, Pakistan
Phone
+92 51 4430626
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000498 Scotmann Pharmaceuticals. · Islamabad
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000498 161 linked products · source seen 25 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx161public portfolio records represented
REG122unique registrations represented
IDX158indexed MedInfoBase presentations
SRC3additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR158current validated price records
G57generic molecules in indexed catalogue
DF9dosage-form groups
TA13therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage98%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage89%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixScotmann PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/scotmann-pharmaceuticalsGenerated 25 Sep 2026Anti-infectives56 · 35%Hematology & thrombosis21 · 13%Cardiovascular21 · 13%Gastrointestinal & hepatology11 · 7%Vitamins, minerals & nutrition11 · 7%CNS & mental health10 · 6%Oncology & immunology9 · 6%Other therapeutic areas19 · 12%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioScotmann PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/scotmann-pharmaceuticalsGenerated 25 Sep 2026158presentationsTablet99 · 63%Capsule24 · 15%Suspension13 · 8%Injection10 · 6%Infusion5 · 3%Sachet2 · 1%Other forms5 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionScotmann PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/scotmann-pharmaceuticalsGenerated 25 Sep 2026140comparable productsBelow peer median50 · 36%Near peer median53 · 38%Above peer median37 · 26%Company median price position-1.7%Lowest-price equivalents20Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsScotmann PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/scotmann-pharmaceuticalsGenerated 25 Sep 2026Nabiqasim Industries (Pvt) Ltd.,31 shared54% overlapWerrick Pharmaceuticals30 shared53% overlapGenome Pharmaceuticals (Pvt.) Ltd.30 shared53% overlapMediate Pharmaceutical Pvt Ltd29 shared51% overlapNeutro Pharma (Pvt.) Ltd.,29 shared51% overlapCCL Pharmaceuticals (Pvt.) Limited28 shared49% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives56 products · 35%
Hematology & thrombosis21 products · 13%
Cardiovascular21 products · 13%
Gastrointestinal & hepatology11 products · 7%
Vitamins, minerals & nutrition11 products · 7%
CNS & mental health10 products · 6%
Oncology & immunology9 products · 6%
Endocrine & metabolic8 products · 5%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluoroquinolone antibacterials15 products · 9%
Anticoagulants14 products · 9%
Antivirals12 products · 8%
Vitamins / minerals / hematinics11 products · 7%
Macrolide antibacterials7 products · 4%
Antiplatelet medicines7 products · 4%
Antipsychotics7 products · 4%
Third-generation cephalosporins6 products · 4%
Formulation footprint

Dosage forms

Tablet99 products
Capsule24 products
Suspension13 products
Injection10 products
Infusion5 products
Sachet2 products
Solution2 products
Syrup2 products
Drops1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 RivascotRivaroxaban 12presentations 10 mg, 15 mg, 2.5 mg, 20 mg · Tablet #2 AmityCiprofloxacin 7presentations 100 mg/50 mL, 125 mg/5 mL, 200 mg/100 mL, 250 mg · Infusion, Suspension, Tablet #3 CefiscotCefixime 6presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Capsule #4 BoldOmeprazole 5presentations 10 mg, 20 mg, 40 mg · Capsule #5 LeafAmlodipine 5presentations 10 mg, 2.5 mg, 5 mg · Tablet #6 MetscotMetformin 5presentations 1000 mg, 250 mg, 500 mg, 850 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median5036% of comparable products
Near market median53within ±5% of median
Above market median3726% of comparable products
Lowest-price equivalents20ties included
Company median price position -1.7% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Metscot 1000 mgMetformin · Extended-release tablet · 50's PKR 2.94/tablet-78.9% vs market median Senora 2.5 mgLetrozole · Tablet · 10's PKR 134.74/tablet-67.1% vs market median Cycloscot 100 mgCiclosporin · Capsule · 5x10's PKR 110.80/capsule-63.2% vs market median Dobro 25 mgSpironolactone · Tablet · 100's PKR 2.12/tablet-57.2% vs market median Enzimox 250 mgAmoxicillin · Capsule · 2×10’s PKR 5.28/capsule-53.2% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 31shared generics Werrick Pharmaceuticals249 products · 82 generics 30shared generics Genome Pharmaceuticals (Pvt.) Ltd.181 products · 84 generics 30shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 29shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 29shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 28shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers121Distinct registrations among indexed, published, presentation-validated products only
Verified price observations287
Products with a verified price158
Products with multiple price observations129
Source records with multiple versions156
Latest portfolio source check22 Sep 2026
Latest effective price date20 Aug 2026
Latest source observation25 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

122 unique registration(s) · 158 indexed presentation(s) · 3 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Enzimox Amoxicillin 250 mg Capsule 2×10’s 028271 PKR 105.58 PKR 5.28/capsule 53% below median
Enzimox Amoxicillin 500 mg Capsule 2×10’s 028272 PKR 211.16 PKR 10.56/capsule 47% below median
Enzimox Amoxicillin 125 mg/5 mL Oral suspension 60ml 028273 PKR 66.87 PKR 1.11/mL 27% below median
Enzimox Amoxicillin 250 mg/5 mL Oral suspension 60ml 028274 PKR 87.99 PKR 1.47/mL 35% below median
Fersip Iron polymaltose complex 50 mg/5 mL Syrup 60 ml 048066 PKR 292.43 PKR 4.87/mL 110% above median
Fersip Iron polymaltose complex 50 mg/mL Oral drops 15ml 048067 PKR 120.02 PKR 8.00/mL Near median
Fersip Elemental Iron 100 mg Tablet 1x10's 056809 PKR 138.75 PKR 13.88/tablet Near median
Flowride Furosemide + Amiloride 40 mg + 5 mg Tablet 3x10's 028293 PKR 129.27 PKR 4.31/tablet 47% below median
Flupenscot Fluphenazine decanoate 25 mg/mL Injection 1's 092339 PKR 151.42 PKR 151.42/vial/unit 42% above median
Flupenscot Fluphenazine decanoate 25 mg Injection 1's 092339 PKR 151.42 PKR 151.42/vial/unit 8% above median
Hepaldi Sofosbuvir 400 mg Tablet 4x7's 080797 PKR 11,392.70 PKR 406.88/tablet 6% below median
Jade Loratadine 10 mg Tablet 30's 028265 PKR 419.34 PKR 13.98/tablet Near median
Jade Loratadine 10 mg Tablet 1x10's 028265 PKR 145.61 PKR 14.56/tablet Near median
Jade Loratadine 5 mg/5 mL Syrup 60ml 028266 PKR 126.19 PKR 2.10/mL 25% above median
Kairo Clarithromycin 250 mg Tablet 1x10's 028215 PKR 582.44 PKR 58.24/tablet 22% above median
Kairo Clarithromycin 500 mg Tablet 1x10's 028216 PKR 970.74 PKR 97.07/tablet 16% above median
Kairo Clarithromycin 125 mg/5 mL Suspension 60ml 028217 PKR 432.96 PKR 7.22/mL Near median
Leaf Amlodipine 2.5 mg Tablet 2x10's 028259 PKR 68.67 PKR 3.43/tablet 38% below median
Leaf Amlodipine 5 mg Tablet 30's 028260 PKR 312.19 PKR 10.41/tablet Near median
Leaf Amlodipine 5 mg Tablet 2x10's 028260 PKR 208.13 PKR 10.41/tablet Near median
Leaf Amlodipine 10 mg Tablet 30's 028261 PKR 356.78 PKR 11.89/tablet 33% below median
Leaf Amlodipine 10 mg Tablet 2x10's 028261 PKR 237.86 PKR 11.89/tablet 33% below median
Leben Clomifene citrate 50 mg Tablet 10's 098490 PKR 398.87 PKR 39.89/tablet Near median
Levoscot Levofloxacin 250 mg Tablet 30's 029925 PKR 1,453.77 PKR 48.46/tablet Near median
Levoscot Levofloxacin 250 mg Tablet 1x10's 029925 PKR 504.78 PKR 50.48/tablet 5% above median
Levoscot Levofloxacin 500 mg Tablet 30's 029926 PKR 2,348.42 PKR 78.28/tablet Near median
Levoscot Levofloxacin 500 mg Tablet 1x10's 029926 PKR 815.42 PKR 81.54/tablet Near median
Losascot Losartan 25 mg Tablet 2x10's 028225 PKR 252.39 PKR 12.62/tablet 11% above median
Losascot Losartan 50 mg Tablet 2x10's 028226 PKR 485.38 PKR 24.27/tablet 17% above median
Losascot Plus 50 Losartan + Hydrochlorothiazide 50 mg + 12.5 mg Tablet 1x10's 028227 PKR 535.17 PKR 53.52/tablet 73% above median
Malfix Artemether + Lumefantrine 120 mg + 20 mg Tablet 16's 077734 PKR 590.91 PKR 36.93/tablet Near median
Malfix Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 077735 PKR 487.50 PKR 60.94/tablet Near median
McStatin Simvastatin 10 mg Tablet 1x10's 028267 PKR 304.68 PKR 30.47/tablet Near median
McStatin Simvastatin 20 mg Tablet 1x10's 028268 PKR 572.45 PKR 57.25/tablet 26% above median
McStatin Simvastatin 40 mg Tablet 1x10's 032954 PKR 766.34 PKR 76.63/tablet 6% above median
Metroscot Metronidazole 500 mg IV infusion 100ml 028304 PKR 137.25 PKR 1.37/mL 24% below median
Metscot Metformin 250 mg Tablet 100's 090303 PKR 176.58 PKR 1.77/tablet 25% below median
Metscot Metformin 500 mg Tablet 50's 090304 PKR 134.09 PKR 2.68/tablet Near median
Metscot Metformin 850 mg Tablet 30's 090305 PKR 110.80 PKR 3.69/tablet 16% below median
Metscot Metformin 1000 mg Tablet 30's 090306 PKR 114.49 PKR 3.82/tablet 8% below median
Metscot Metformin 1000 mg Extended-release tablet 50's 091953 PKR 147.00 PKR 2.94/tablet 79% below median
Morfscot Morphine 10 mg Injection 1ml×100’s 028300 PKR 457.51 PKR 4.58/mL No comparator
Morfscot Morphine 20 mg Injection 1ml×100’s 028301 PKR 703.86 PKR 7.04/mL No comparator
Morfscot Morphine 30 mg Injection 1ml×100’s 028302 PKR 879.83 PKR 8.80/mL No comparator
Moxara Moxifloxacin 400 mg Tablet 5's 102629 PKR 877.13 PKR 175.43/tablet Near median
Mozart Risperidone 3 mg Tablet 1x10's 028255 PKR 634.88 PKR 63.49/tablet 9% above median
Mozart Risperidone 4 mg Tablet 1x6's 028256 PKR 407.70 PKR 67.95/tablet 7% below median
Mozart Risperidone 4 mg Tablet 10's 028256 PKR 679.51 PKR 67.95/tablet 7% below median
Mozart Risperidone 1 mg Tablet 5x10's 028922 PKR 873.68 PKR 17.47/tablet 25% below median
Mozart Risperidone 2 mg Tablet 5x10's 028923 PKR 1,747.35 PKR 34.95/tablet 6% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Scotmann Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 25, 2026, from https://medinfobase.com/company/scotmann-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.